Business Wire

CA-CYOLO

21.2.2024 14:31:29 CET | Business Wire | Press release

Share
New Research from Cyolo and Ponemon Institute Identifies Significant Gaps in Securing Access to Connected OT Environments

Today, Cyolo, the access company for the digital enterprise, in partnership with Ponemon Institute, released a global study exploring how organizations that operate critical infrastructure, industrial control systems (ICS), and other operational technology (OT) systems are managing access and risk in an era of rising connectivity.

“Our world has become increasingly interconnected, and the findings of this report highlight the vital need for organizations to reevaluate and enhance their strategies for ensuring secure access into OT environments,” said Larry Ponemon, Chairman and Founder of the Ponemon Institute.

The report, “Managing Access & Risk in the Increasingly Connected Operational Technology (OT) Environment,” reveals that many industrial organizations lack the resources, expertise, and collaborative processes to effectively mitigate threats and ensure secure access to OT systems. The report is based on a survey of 1,056 security professionals across the United States and EMEA who work in organizations that run an OT environment and are knowledgeable about their organization’s approach to managing OT security and risk.

Ensuring secure access to OT environments is about more than just cybersecurity. These environments contain highly sensitive systems and critical infrastructure responsible for keeping manufacturing lines running, water and electricity flowing, and performing other tasks vital to the smooth functioning of our communities.

OT systems were historically isolated for security reasons but are now facing increased connectivity to IT networks and the internet (sometimes called IT/OT convergence). At the same time, more third-party vendors and contractors are being given remote access to OT environments. These shifts introduce serious new risks that can leave organizations exposed to safety and security threats if access and connectivity are not properly controlled.

Overall key findings include:

  • Organizations allow dozens of third-party users to access OT environments. 73% permit third-party access to OT environments, with an average of 77 third parties per organization granted such access. Challenges to securing third-party access include preventing unauthorized access (44%), aligning IT and OT security priorities (43%), and giving users too much privileged access (35 percent).
  • Visibility into industrial assets is dismal. 73% lack an authoritative OT asset inventory, putting organizations at significant risk.
  • IT and OT teams share responsibility for OT security but do not communicate enough to achieve optimal outcomes. 71% report that IT or IT and OT together are responsible for securing OT environments. However, collaboration and communication are lacking, with 37% reporting little or no collaboration, and 19% reporting that teams talk about OT security issues only when an incident occurs.
  • Security is seen not only as a goal of IT/OT convergence but also as an obstacle. Reducing security risk is the top objective of companies pursuing IT/OT convergence (59%), and yet one-third (33%) of organizations not pursuing convergence cite security risk as a top factor for their decision.

“We are at a crucial point in the evolution of OT security, and the need to secure access to critical systems from internal and external threats is more urgent than ever. The stakes are exceptionally high, as a breach could jeopardize not just data but also the functioning of critical infrastructure, risking the safety of workers and the environment,” said Joe O'Donnell, Executive Vice President of Corporate Development and General Manager of OT at Cyolo. “This research reveals a pressing need for new approaches, especially in areas like third-party and privileged access, the security of legacy systems, and collaboration between IT and OT teams. Cyolo is dedicated to supporting organizations in navigating these challenges and working towards a secure, resilient future for OT environments.”

Access the full report here.

Register to attend a joint webinar from Cyolo and Ponemon Institute, on Tuesday, March 12 at 11am ET here: Behind the Ponemon Report: Risk & Access Management in the OT Environment.

During this session Dr. Larry Ponemon will share top insights from the research, with industry analysis added by Cyolo’s Joe O’Donnell and Adi Karisik, Global Principal for OT Cybersecurity at Jacobs Engineering.

About Cyolo

Cyolo enables privileged remote operations by connecting verified identities directly to applications with continuous authorization throughout the connection. Purpose-built for deployment in every type of environment, Cyolo’s Remote Privileged Access Management (RPAM) solution combines multiple security functions required to mitigate high risk access, including zero-trust access for users and devices, MFA for the last mile, IdP capabilities, credentials vault, secure file transfer, supervised access, session recording, and much more into a single, cost-effective, easy to deploy, and user-friendly platform.

Consolidate your security stack and experience the power of seamless and secure operations across any application in any environment, from critical infrastructure to cloud. Visit https://cyolo.io/ to learn more.

About Ponemon Institute

Ponemon Institute is dedicated to independent research and education that advances responsible information and privacy management practices within business and government. Our mission is to conduct high quality, empirical studies on critical issues affecting the management and security of sensitive information about people and organizations. We uphold strict data confidentiality, privacy and ethical research standards. We do not collect any personally identifiable information from individuals (or company identifiable information in our business research). Furthermore, we have strict quality standards to ensure that subjects are not asked extraneous, irrelevant or improper questions.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240221222283/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sharjah Ruler Receives Portugal’s Grand Collar of Order of Camões31.1.2026 18:27:00 CET | Press release

His Excellency Marcelo Rebelo de Sousa, President of the Portuguese Republic, awarded His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the Grand Collar of the Order of Camões (Grande Colar da Ordem de Camões), the highest sovereign cultural order in Portugal. His Highness is the first Arab figure to receive the Order of Camões and the sixth recipient worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131119526/en/ Sharjah Ruler receives Portugal’s Grand Collar of Order of Camões (Photo: AETOSWire) The honour was conferred during a ceremony hosted by the Portuguese President at the Presidential Palace in Lisbon. The event was attended by Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority, alongside senior officials. The ceremony recognised His Highness’s prominent global stature, as a leading figure in culture, intellectual thought and in

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye